Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith ...

Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American: MTNB), currently trading at $0.55 with a market capitalization of $2.79 million, disclosed in a recent SEC filing that Eric Ende ...

Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American: MTNB), currently trading at $0.55 with a market capitalization of $2.79 million, disclosed in a recent SEC filing that Eric Ende, the ...

Matinas BioPharma (MTNB) announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as ...

Matinas BioPharma Holdings, Inc. BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry ...

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward ...

Thank you for your patience and understanding. About Matinas BioPharmaMatinas BioPharma is a biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal ...

Matinas BioPharma appoints Keith Murphy and Edward Neugeboren to its Board of Directors, while Matthew Wikler and Natasha Giordano resign. Matinas BioPharma Holdings, Inc. announced the addition ...

(MENAFN- GlobeNewsWire - Nasdaq) BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry ...

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward ...